Volker Diehl, MD, PhD, founder of the German Hodgkin Lymphoma Study Group, receives a lifetime achievement award from the American Society of Hematology. Medscape Medical News
Patients treated with romiplostim vs standard of care had better platelet response, less treatment failure and splenectomy, less bleeding, and higher quality of life. Medscape Medical News
The incidence of thromboembolic events in patients receiving cisplatin-based chemotherapy is unacceptably high, a retrospective analysis concludes. Medscape Medical News
A counterfeit product labeled Avastin that is circulating in the United States contains no active ingredient, so cancer patients might be missing out on treatment. News Alerts